DeepHow, the AI company that turns know-how into smart, how-to training videos, launches its AI-powered training platform for manufacturers and field-service teams.

An industry first, Taliware’s Biombeat launches an SDK so that developers can combine a person’s ECG biometrics with geolocation for maximum security.

Kintone CEO Dave Landa is publishing a series of articles about how to shepherd an organization through a digital transformation.

Ravi sits down with host Klaudia Tirico to chat about the importance of MQMs in today's work-from-home world.

Senturion+ launches an advanced, natural material called Viruend that catches and kills at least 25% more SARS-CoV-2 and other viruses than standard N95 masks.

CureLab Oncology forms veterinary oncology subsidiary to fight pet cancer—and gain valuable insights into the mechanism of its Elenagen™ gene therapy

Dr. David Soane, founder and CEO of Transform Materials, explains how his company’s technology reduces harmful greenhouse gas emissions at shale wells while yielding two valuable by-products.

IndustryWeek profiles how DeepHow is helping manufacturers dramatically simplify the complex and costly process of creating training videos that capture expert know-how.

rBIO's platform for synthetic insulin achieves success as the team looks to production scale-up and a range of other prescription drugs to target.

With BioCube’s cool wet labs now up and running, the next wave of budding biotech companies have a good reason to locate closer to San Jose.

AI-in-Sensor specialist AIStorm closed out 2020 with $16M extra in the bank. After its $13.2M Series A announcement and product news in early 2019, the company has been focused on building customers and strategic partners. 2021 promises to be a big year.

With all trade shows and marketing events now taking place virtually, attendee engagement at virtual events has become a major challenge for marketers. Jifflenow has the solution.

The pre-IND briefing package was centered around a proposed Phase II US clinical trial for CureLab’s experimental cancer-fighting DNA vaccine.

Following Transform Materials’ recent launch, Chemical Engineering profiled CEO Dr. David Soane in the November edition.

CureLab is developing an investigational DNA vaccine called Elenagen, which reverses tumor grade, changes tumor microenvironment, and stimulates an immune attack on the tumor.

ZingPR and Bioinsider convene biotech experts to network, exchange ideas and address timely issues in science and healthcare.